HER2-negative breast cancer patients with brain metastases

Clinical trials for HER2-negative breast cancer patients with brain metastases explained in plain language.

Never miss a new study

Get alerted when new HER2-negative breast cancer patients with brain metastases trials appear

Sign up with your email to follow new studies for HER2-negative breast cancer patients with brain metastases, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug cocktail aims to shrink brain tumors in breast cancer patients

Disease control Recruiting now

This phase 2 trial is testing whether the combination of utidelone and capecitabine can shrink brain tumors in people with HER2-negative breast cancer that has spread to the brain. About 120 participants will receive either utidelone alone or with capecitabine. The main goal is t…

Matched conditions: HER2-NEGATIVE BREAST CANCER PATIENTS WITH BRAIN METASTASES

Phase 2 • Sponsor: Biostar Pharma, Inc. • Aim: Disease control

Last updated Aug 23, 2026 00:00 UTC

HER2-negative breast cancer patients with brain metastases

Get alerted when new HER2-negative breast cancer patients with brain metastases trials appear

New drug cocktail aims to shrink brain tumors in breast cancer patients